Nasal in situ gel containing hydroxy propyl β-cyclodextrin inclusion complex of artemether: Development and in vitro evaluation

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 70, Issue 1-2, 2011, Pages 49-58

  Mahajan, Hitendra S ^a   Shah, Saurabh K ^a   Surana, Sanjay J ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

In situ gel; Inclusion mode; Mucoadhesion; Phase solubility; Temperature induced gelation

Indexed keywords

EID: 79956057329     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-010-9861-x     Document Type: Article

References (33)

1. GA Balint 2001 Artemisinin and its derivatives: an important new class of antimalarial agents Pharmacol. Ther. 90 261 265 10.1016/S0163-7258(01)00140-1 1:CAS:528:DC%2BD3MXntV2hurw%3D (Pubitemid 32913479)
2. JK Baker RH Yarber CD Hufford IS Lee HN Elsohly JD McChesney 1988 Thermospray mass spectroscopy/high performance liquid chromatographic identification of the metabolites formed from arteether using a rat liver microsome preparation Biomed. Environ. Mass. Spectrom. 18 337 351 10.1002/bms.1200180509 (Pubitemid 19116520)
3. J Balasubramaniam S Kant JK Pandit 2003 In vitro and in vivo evaluation of the Gelrite® gellan gum-based ocular delivery system for indomethacin Acta Pharm. 53 251 261 1:CAS:528:DC%2BD2cXlvFSntA%3D%3D (Pubitemid 38083940)
4. Behl, C.R., Harper, N.J., Pei, J.Y.: A general method of accessing skin permeatin enhancement mechanisms and optimization. In: Hsies, D.S., (eds.) Drug permeation enhancement: theory and applications, 1st edn, p. 115. New York, NY: Marcel Dekker Inc (1994)
5. B Yang J Lin Y Chen Y Liu 2009 Artemether/hydroxypropyl-b cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode Bioorg. Med. Chem. 17 6311 6317 10.1016/j.bmc.2009.07.060 1:CAS:528:DC%2BD1MXhtVenurzN
6. ME Brewster T Loftsson 2002 The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems Pharmazie 57 94 1:CAS:528:DC%2BD38XhsFCnu74%3D
7. LE Bromberg ES Ron 1998 Protein and peptide release from temperature responsive gels and thermogelling polymer matrices Adv. Drug Deliv. Rev. 31 197 221 10.1016/S0169-409X(97)00121-X 1:CAS:528:DyaK1cXhvVSjsLg%3D (Pubitemid 28191866)
8. G Castronuovo M Niccoli 2006 Thermodynamics of inclusion complexes of natural and modified cyclodextrins with propanolol in aqueous solution at 298 K Bioorg. Med. Chem. 14 3883 3887 10.1016/j.bmc.2006.01.052 1:CAS:528: DC%2BD28XjvFWmsLY%3D (Pubitemid 44316610)
9. ME Davis ME Brewster 2004 Cyclodextrin-based pharmaceutics: past, present, future Nat. Rev. Drug Discov. 3 1023 10.1038/nrd1576 1:CAS:528:DC%2BD2cXhtVarsL3P (Pubitemid 39642365)
10. J Desai K Alexander A Riga 2006 Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release Int. J. Pharm. 308 115 123 10.1016/j.ijpharm.2005.10.034 1:CAS:528:DC%2BD28Xls1Srsg%3D%3D (Pubitemid 43097242)
11. D Duchene D Wouessidjewe G Poncel 1999 Cyclodextrins and carrier systems J. Control. Release 62 263 268 10.1016/S0168-3659(99)00046-2 1:CAS:528:DyaK1MXmsV2qs7k%3D (Pubitemid 29486506)
12. K Edsman J Carlfors R Petersson 1998 Rheological evaluation of poloxamer as an in situ gel for ophthalmic use Eur. J. Pharm. Sci. 6 105 112 10.1016/S0928-0987(97)00075-4 1:CAS:528:DyaK1cXhsFejt74%3D (Pubitemid 28164280)
13. M Foley L Tilley 1997 Qinghaosu (artemisinin): an antimalarial drug from China Int. J. Parasitol. 27 213 10.1016/S0020-7519(96)00152-X (Pubitemid 27139713)
14. CL Graff GM Pollack 2005 Nasal drug administration: potential for targeted central nervous system delivery J. Pharm. Sci. 94 1187 1195 10.1002/jps.20318 1:CAS:528:DC%2BD2MXkvF2qt7Y%3D (Pubitemid 40904183)
15. B Greenwood T Mutabingwa 2002 Malaria in 2002 Nature 415 670 672 10.1038/415670a 1:CAS:528:DC%2BD38XhsVCjtrg%3D (Pubitemid 34136399)
16. ID Gonjari PV Kasture 2007 Temperature induced in situ mucoadhesive gel of Tramadol hydrochlioride for nasal drug delivery J. Pharm. Res. 6 2 89 93 1:CAS:528:DC%2BD2sXhtFOnsbjF
17. S Gould RC Scott 2005 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): a toxicology review Food Chem. Toxicol. 43 1451 10.1016/j.fct.2005.03.007 1:CAS:528:DC%2BD2MXmt1eiu78%3D (Pubitemid 40961909)
18. TT Hien TM Davis LV Chuong KF Ilett DX Sinh NH Phu C Agus GM Chiswell NJ White J Farrar 2004 Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria Antimicrob. Agents Chemother. 48 4234 4239 10.1128/AAC.48.11.4234-4239.2004 1:CAS:528: DC%2BD2cXpvVyksL0%3D (Pubitemid 39434880)
19. T Irie K Uekama 1997 Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation J. Pharm. Sci. 86 147 10.1021/js960213f 1:CAS:528:DyaK2sXhtVOgsLY%3D (Pubitemid 27078377)
20. Jiang, X., et al.: A novel nasal delivery system of a Chinese traditional medicine, Radix Bupleuri, based on the concept of ion-activated in situ gel. Arch. Pharm. Res. 30(8), 1014-1019 (2007). http://apr.psk.or.kr
21. H Jomaa J Wiesner S Sanderbrand B Altincicek C Weidemeyer M Hintz I Tübachova M Eberl J Zeider HK Liechtenthaler D Soldati E Beck 1999 Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs Science 285 1573 10.1126/science.285.5433.1573 1:CAS:528:DyaK1MXlslOqsrY%3D (Pubitemid 29420582)
22. Kiechel, J. R., Malmison, R.: Nasal compositions. US Patent: 4,885,305 (1989)
23. Klayman, D.: Qinghaosu (artemisinin). An antimalarial drug from China. Science 228, 1049-1055 (1989)
24. T Loftsson ME Brewster 1996 Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization J. Pharm. Sci. 85 1017 1025 10.1021/js950534b 1:CAS:528:DyaK28XlsFSrsr4%3D (Pubitemid 26338912)
25. T Loftsson T Järvinen 1999 Cyclodextrins in ophthalmic drug delivery Adv. Drug Deliv. Rev. 36 59 10.1016/S0169-409X(98)00055-6 (Pubitemid 29074477)
26. JL Maggs LPD Bishop G Edwards PM O'Neill SA Ward PA Winstanley N Mturi CO Musumba BM Wamola BR Ogutu CR Newton 2003 Cerebral malaria: optimising management CNS Drugs 17 153 165 10.2165/00023210-200317030-00002 (Pubitemid 36286532)
27. Murthy, R. S. R., Majithiya, R. J., Ghosh P. K.: Thermoreversible- mucoadhesive gel for nasal delivery of Sumatriptan. AAPS PharmSciTech. 7(3), E1-E7 (2006). ( http://www.aapspharmscitech.org )
28. NA Peppas P Bures W Leobandung H Ichikawa 2000 Hydrogels in pharmaceutical formulations Eur. J. Pharm. Biopharm. 50 27 46 10.1016/S0939-6411(00)00090-4 1:CAS:528:DC%2BD3cXjslyju7Y%3D (Pubitemid 30326687)
29. E Ruel-Gariepy JC Leroux 2004 In situ forming hydrogels-review of temperature- sensitive systems Eur. J. Pharm. Biopharm. 58 409 426 10.1016/j.ejpb.2004.03.019 1:CAS:528:DC%2BD2cXmsVGnsL8%3D (Pubitemid 39037244)
30. Shrivastava A., Nagori B.P., Saini P, Issarani R., Gaur S.S.: New simple and economical spectrophotometric method for estimation of artemether in pharmaceutical dosage forms. Asian J. Res. Chem. 1, 19-21 (2008)
31. S Türker E Onur Y Ö zur 2004 Nasal route and drug delivery systems Pharm. World Sci. 26 137 142 10.1023/B:PHAR.0000026823.82950.ff (Pubitemid 39012580)
32. K Uekama F Hirayama T Irie 1998 Cyclodextrin drug carrier systems Chem. Rev. 98 2045 10.1021/cr970025p 1:CAS:528:DyaK1cXksV2itr0%3D
33. CS Yong JS Choi JD Rhee 2001 Effect of sodium chloride on the gelation temperature, gel strength, and bioadhesive force of poloxamer gels containing diclofenac sodium Int. J. Pharm. 226 195 205 10.1016/S0378-5173(01)00809-2 1:CAS:528:DC%2BD3MXmsV2jtrw%3D (Pubitemid 32800794)